| Atnahs Pharma Switzerland AG - Tenormin submite, Tabletten |
| 39879 | | 03 | | Tenormin submite | | Tabletten | | C07AB03 | | Atenolol | | 26.03.1991 | | |
|
| Composition |
| atenololum 25 mg, magnesii subcarbonas ponderosus, maydis amylum, natrii laurilsulfas corresp. natrium 0.14 mg, gelatina, magnesii stearas, hypromellosum, glycerolum, titanii dioxidum, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Atenolol | 25 mg |
| | BAG: Active Agent | Dose |
|---|
| Atenolol | 25 mg |
| | | | Inactive agents |
|---|
| Gelatina | | Glycerol | | Hypromellosum | | Magnesii Stearas | | Magnesii Subcarbonas Ponderosus | | Maydis Amylum | | Natrii Laurilsulfas | | Pro Compresso | | Titanium Dioxide |
| |
|
| Teilbarkeit |
| | Ja | | | | Möglich | | | | Möglich | | | | -- | | | | Resorption kann verändert sein | | | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 077 | 30 Tablet(s) | 2.64 | 12.05 | B | SL | No | | 085 | 100 Tablet(s) | 7.81 | 17.65 | B | SL | No |
|
